comparemela.com

Latest Breaking News On - Carbonic anhydrase - Page 9 : comparemela.com

Oncotarget: mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC

Oncotarget: mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

Carbonic Anhydrases Research Tools from BioVision : Get Quote, RFQ, Price or Buy

Carbonic Anhydrases Research Tools from BioVision : Get Quote, RFQ, Price or Buy
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

Radiopharmaceuticals Global Market Report 2020-30: COVID-19 Growth and Change

Share: New York, Dec. 15, 2020 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Radiopharmaceuticals Global Market Report 2020-30: COVID-19 Growth and Change - https://www.reportlinker.com/p05996812/?utm source=GNW (A Subsidiary of Sterigenics International), Mallinckrodt plc and Curium. The global radiopharmaceuticals market is expected to decline from $5.07 billion in 2019 to $4.78 billion in 2020 at a compound annual growth rate (CAGR) of -5.72%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $5.88 billion in 2023 at a CAGR of 7.13%.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.